These include: Large disc extrusions or sequestered fragments requiring surgical intervention Severe spinal stenosis with significant canal narrowing Bone spurs (osteophytes) compressing nerve structures Advanced degenerative disc disease with complete disc height loss Spondylolisthesis (vertebral slippage) beyond grade 1 Cauda equina syndrome (medical emergency requiring immediate surgery) Users with these conditions typically report minimal improvement from peptide therapy alone
Call Us: Contact our friendly team to schedule an appointment at a time that suits you
Achieving balance and optimal health of the gut can be pursued through BPC-157 Gut Health Peptide Therapy
Various dietary interventions, including carbohydrate, fat and, more recently, amino acid restriction, have been explored to combat this epidemic 3,4,5,6
If this occurs, discontinue use immediately
A phase 1 clinical trial was conducted to evaluate the safety and pharmacokinetics of BPC 157 compared to placebo in healthy volunteers, with results reportedly submitted to ClinicalTrials.gov on May 23, 2016
